Welcome to ADAPT SMART …  enabling platform for the coordination of Medicines Adaptive Pathways to Patients (MAPPs) activities. MAPPs seeks to foster access to beneficial treatments for the right patient groups at the earliest appropriate time in the product life-span in a sustainable fashion.

ADAPT SMART will support IMI2 projects investigating MAPPs tools and methodologies, and engage in a dialogue with all relevant stakeholders to prove and develop workable MAPPs concepts. The ADAPT SMART consortium aims to facilitate and accelerate the availability of MAPPs to all healthcare stakeholders. It will:
  • Distribute findings, key discoveries and case studies from ongoing or completed MAPPs pilot projects, creating a MAPPs repository of knowledge and opportunities
  • Identify the scientific challenges and opportunities related to the implementation of MAPPs and foster the aligned understanding of consortium members and their constituents
  • Support new IMI2 research and innovation actions by facilitating the inclusion of MAPPs enablers, tools and methodologies to address its challenges and opportunities
  • Conduct horizon scanning and research on key topics to produce actionable advice and recommendations for IMI and other stakeholders to further the broad implementation and adoption of MAPPs
ADAPT SMART will centre its initial work on four key work packages.

Recent News


ADAPT SMART General Assembly – 18 January 2017

18th January 2017

London, United Kingdom

On the 18th of Janaury, ADAPT SMART hosted it’s Annual Meetings and General Assembly at the EMA in London.

EMA hosts a Workshop on Adaptive Pathways

8th December 2016

London, United Kingdom

On the 8th of December 2016, the European Medicines Agency has organised a workshop in collaboration with the European Commission to gather the views and proposals from stakeholders on the adaptive pathways approach.